Lipid storage |
MBD-R2
|
none |
0.013111106 |
|
19067489
|
Lipid storage |
MBD-R2
|
none |
1.265434178 |
|
19067489
|
Histone pre-mRNA processing |
MBD-R2
|
Histone pre-mRNA processing defect |
3 |
|
18042462
|
Hedgehog signaling |
MBD-R2
|
Increased Hedgehog reporter activity |
5.37 |
|
16311596
|
Constitutive protein secretion and Golgi organization (1) |
MBD-R2
|
Decreased horseradish peroxidase protein expression |
sp |
|
16452979
|
Cell size and cell-cycle regulation (1) |
MBD-R2
|
none |
sp |
|
16496002
|
Muscle morphogenesis and function (1) |
MBD-R2
|
Lethal |
np |
|
20220848
|
Heat nociception (1) |
MBD-R2
|
none |
-1.17 |
|
21074052
|
Heart development and function (1) |
MBD-R2
|
none |
1 |
|
20371351
|
Serratia marcescens infection (1) |
MBD-R2
|
none |
-0.0714285714285714 |
|
19520911
|
Notch pathway regulation (4) |
MBD-R2
|
Completely lethal (pupal) |
sp |
|
19363474
|
G2-M DNA damage checkpoint regulation (2) |
MBD-R2
|
Increased histone H3 phosphorylation with doxorubicin |
23.1 |
with doxorubicin |
21205937
|
G2-M DNA damage checkpoint regulation (2) |
MBD-R2
|
Increased histone H3 phosphorylation with etoposide |
37.18 |
with etoposide |
21205937
|
G2-M DNA damage checkpoint regulation (2) |
MBD-R2
|
Increased histone H3 phosphorylation after X-ray exposure |
38.53 |
X-ray exposure |
21205937
|
G2-M DNA damage checkpoint regulation (2) |
MBD-R2
|
none |
11.41 |
with bleocin |
21205937
|
Hh pathway regulation |
MBD-R2
|
Upregulation of Hh pathway |
1.44219612320321 |
|
17903264
|
Hh pathway regulation |
MBD-R2
|
Upregulation of Hh pathway |
1.71168959278122 |
|
17903264
|
Self-renewal and differentiation in neural stem cells |
MBD-R2
|
GFP aggregates number, GFP aggregates size, neuroblast cell shape, ganglion mother cell shorter lineages, ganglion mother cell shape, neuroblast underproliferation, lethal |
sp |
|
21549331
|
Adiposity regulation (1) |
MBD-R2
|
none |
-0.135 |
|
20074523
|
RTK-Ras-ERK pathway regulation (1) |
MBD-R2
|
none |
0.13 |
0 minutes EGF stimulation |
22028469
|
RTK-Ras-ERK pathway regulation (1) |
MBD-R2
|
Decreased ERK phosphorylation after EGF stimulation |
-4.34 |
10 minutes EGF stimulation |
22028469
|
RTK-Ras-ERK pathway regulation (2) |
MBD-R2
|
none |
-0.27 |
10 minutes sSpitz stimulation |
22028469
|
RTK-Ras-ERK pathway regulation (2) |
MBD-R2
|
none |
-0.81 |
30 minutes sSpitz stimulation |
22028469
|
Hippo pathway regulation |
MBD-R2
|
none |
0.92 |
|
23263283
|
Glycosylation regulation (1) |
MBD-R2
|
Increased alpha1,3-fucose Chp glycosylation, increased alpha1,6-fucose Chp glycosylation |
sp |
|
21203496
|
Glycosylation regulation (2) |
MBD-R2
|
Effect on Chp glycosylation |
np |
|
21203496
|